Package 55566-1050-2

Brand: adstiladrin

Generic: nadofaragene firadenovec-vncg
NDC Package

Package Facts

Identity

Package NDC 55566-1050-2
Digits Only 5556610502
Product NDC 55566-1050
Product ID 55566-1050_a47aadc2-f4fa-4ac5-b5de-7d9d707b381b
Description

20 mL in 1 VIAL (55566-1050-2)

Marketing

Marketing Status
Marketed Since 2025-10-13
Brand adstiladrin
Generic nadofaragene firadenovec-vncg
Sample Package No

Linked Drug Pages (1)

ADSTILADRIN ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVESICAL"], "spl_id": "a47aadc2-f4fa-4ac5-b5de-7d9d707b381b", "openfda": {"unii": ["0OOS09O1FH"], "rxcui": ["2644440", "2644445"], "spl_set_id": ["5ca20ed4-da4f-463c-ac2a-ccd6ab3774fa"], "manufacturer_name": ["Ferring Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (55566-1050-1)  / 20 mL in 1 VIAL (55566-1050-0)", "package_ndc": "55566-1050-1", "marketing_start_date": "20230905"}, {"sample": false, "description": "20 mL in 1 VIAL (55566-1050-2)", "package_ndc": "55566-1050-2", "marketing_start_date": "20251013"}], "brand_name": "ADSTILADRIN", "product_id": "55566-1050_a47aadc2-f4fa-4ac5-b5de-7d9d707b381b", "dosage_form": "SUSPENSION", "product_ndc": "55566-1050", "generic_name": "nadofaragene firadenovec-vncg", "labeler_name": "Ferring Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADSTILADRIN", "active_ingredients": [{"name": "NADOFARAGENE FIRADENOVEC", "strength": "300000000000 {VP}/mL"}], "application_number": "BLA125700", "marketing_category": "BLA", "marketing_start_date": "20230905", "listing_expiration_date": "20261231"}